EyePoint Pharmaceuticals Inc (EYPT)
7.33
+0.08
(+1.10%)
USD |
NASDAQ |
Dec 24, 16:00
EyePoint Pharmaceuticals Free Cash Flow: -118.04M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cassava Sciences Inc | -78.07M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Adverum Biotechnologies Inc | -86.06M |
| Regenxbio Inc | -184.74M |
| Editas Medicine Inc | -191.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -39.03M |
| Cash from Investing (Quarterly) | 16.20M |
| Cash from Financing (Quarterly) | 11.89M |
| Free Cash Flow Per Share (Quarterly) | -0.7457 |
| Free Cash Flow to Equity (Quarterly) | -40.60M |
| Free Cash Flow Yield | -31.77% |